Metabolic syndrome and risk of cancer: a systematic review and meta-analysis.
Metabolic syndrome and risk of cancer: a systematic review and meta-analysis.
复制标题
DOI:
10.2337/dc12-0336
复制
发表时间:
2012-11
期刊:
影响因子:
16.2
通讯作者:
Giugliano D
中科院分区:
文献类型:
--
作者:
Esposito K;Chiodini P;Colao A;Lenzi A;Giugliano D
Available evidence supports the emerging hypothesis that metabolic syndrome may be associated with the risk of some common cancers. We did a systematic review and meta-analysis to assess the association between metabolic syndrome and risk of cancer at different sites. We conducted an electronic search for articles published through October 2011 without restrictions and by reviewing reference lists from retrieved articles. Every included study was to report risk estimates with 95% CIs for the association between metabolic syndrome and cancer. We analyzed 116 datasets from 43 articles, including 38,940 cases of cancer. In cohort studies in men, the presence of metabolic syndrome was associated with liver (relative risk 1.43, P < 0.0001), colorectal (1.25, P < 0.001), and bladder cancer (1.10, P = 0.013). In cohort studies in women, the presence of metabolic syndrome was associated with endometrial (1.61, P = 0.001), pancreatic (1.58, P < 0.0001), breast postmenopausal (1.56, P = 0.017), rectal (1.52, P = 0.005), and colorectal (1.34, P = 0.006) cancers. Associations with metabolic syndrome were stronger in women than in men for pancreatic (P = 0.01) and rectal (P = 0.01) cancers. Associations were different between ethnic groups: we recorded stronger associations in Asia populations for liver cancer (P = 0.002), in European populations for colorectal cancer in women (P = 0.004), and in U.S. populations (whites) for prostate cancer (P = 0.001). Metabolic syndrome is associated with increased risk of common cancers; for some cancers, the risk differs betweens sexes, populations, and definitions of metabolic syndrome.
登录
查看更多内容
DOI:
10.1016/j.numecd.2009.02.006
发表时间:
2010-01
期刊:
Nutrition, metabolism, and cardiovascular diseases : NMCD
影响因子:
--
作者:
Agnoli C;Berrino F;Abagnato CA;Muti P;Panico S;Crosignani P;Krogh V
通讯作者:
Krogh V
DOI:
10.1158/1055-9965.epi-09-0235
发表时间:
2009-07
期刊:
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
影响因子:
--
作者:
Kabat GC;Kim M;Chlebowski RT;Khandekar J;Ko MG;McTiernan A;Neuhouser ML;Parker DR;Shikany JM;Stefanick ML;Thomson CA;Rohan TE
通讯作者:
Rohan TE
影响因子:
24
作者:
Jafri, Haseeb;Alsheikh-Ali, Alawi A.;Karas, Richard H.
通讯作者:
Karas, Richard H.
影响因子:
2.8
作者:
De Nunzio, Cosimo;Freedland, Stephen J.;Tubaro, Andrea
通讯作者:
Tubaro, Andrea
影响因子:
37.8
作者:
Alberti, K. G. M. M.;Eckel, Robert H.;Smith, Sidney C., Jr.
通讯作者:
Smith, Sidney C., Jr.